Posted on 11/6/19
Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological . . .
Posted on 11/5/19
Seattle Genetics and BeiGene Announce Global License Agreement
BOTHELL, Wash. & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160) today announced that the companies have entered . . .
Posted on 11/5/19
Innovative Management Solutions New York Partners with Arcadia.io
Population health management leader Arcadia (www.arcadia.io) announced today a partnership with Innovative Management Solutions (IMSNY), a joint venture between Coordinated Behavioral Care (CBC) and Coordinated Behavioral . . .
Posted on 11/5/19
Curis Reports Third Quarter 2019 Financial Results
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the . . .
Posted on 11/5/19
Seres Therapeutics Reports Third Quarter Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today reported financial results for the three months ended September 30, 2019 and provided a business update.“Seres continues to . . .
Posted on 11/5/19
Novanta Announces Financial Results for the Third Quarter 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2019.Third . . .
Posted on 11/5/19
BioDirection Announces Manufacturing Facility in Albuquerque, NM
BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and management of concussion and other traumatic brain . . .
Posted on 11/4/19
Amulet Capital’s OPEN Health Merges with Pharmerit International
Transaction creates the leading provider of HEOR, market access, medical affairs and healthcare communications services to pharmaceutical companies across US, Europe and Asia LONDON & BETHESDA, . . .
Posted on 11/4/19
Is There Still Room to Profit From Biogen?
For decades, every tale in the world of Alzheimer's drug development has followed the same story arc: first a period of hope, expensive effort, and no . . .
Posted on 11/1/19
ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in . . .
Posted on 11/1/19
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
Just two weeks ago, Bristol-Myers Squibb's (NYSE:BMY) share price was barely where it was at the beginning of 2019. But the big drugmaker reported some positive . . .
Posted on 10/31/19
Pandion and Astellas Announce Collaboration
Exclusive Collaboration Utilizes Pandion’s Platform to Discover Novel Tissue-Specific Immunomodulators for Type 1 Diabetes and Other Autoimmune Diseases of the PancreasPandion Therapeutics, Inc., and Astellas Pharma . . .
Posted on 10/31/19
TetraScience Closes $8M Series A
TetraScience, developers of the industry's first cloud-based data integration platform for life sciences R&D, today announced
Posted on 10/31/19
Dicerna Enters Agreement with Roche
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced a research collaboration and licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) to develop novel therapies . . .
Posted on 10/31/19
Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced that it has entered into a collaboration and license agreement . . .
Posted on 10/31/19
Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2020 revenue of $205.0 million, . . .
Posted on 10/30/19
Tetraphase Pharmaceuticals Announces $8 Million Registered Direct Offering Priced At-the-Market
WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline for injection) to treat serious and life-threatening infections, today . . .
Posted on 10/30/19
Pear Therapeutics Announces Agreement with Ironwood Pharmaceuticals
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. announced today that it has entered into an agreement with Ironwood Pharmaceuticals, Inc. to evaluate Prescription Digital Therapeutics (PDTs) for the treatment . . .
Posted on 10/30/19
Sherlock Biosciences and Mologic Establish Strategic Partnership
CAMBRIDGE, Mass., and BEDFORDSHIRE, UK--(BUSINESS WIRE)--Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, and Mologic Ltd, a leading developer . . .
Posted on 10/30/19
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT
PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, . . .
Posted on 10/30/19
ArQule Reports Third Quarter 2019 Financial Results
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the third quarter of 2019.For the quarter ended September 30, 2019, the Company reported . . .
Posted on 10/30/19
Abacus Health Products Expands Its CBDMEDIC Offering to Major Retail Pharmacy Chain
WOONSOCKET, R.I. & TORONTO--(BUSINESS WIRE)--Abacus Health Products, Inc. (CSE: ABCS, OTCQX:ABAHF) today announced that an additional major national retail pharmacy chain in the United States will . . .
Posted on 10/30/19
Arranta Bio Announces $82M In New Funding
Arranta Bio announced today the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific.
Posted on 10/30/19
Biogen Hasn't Cured Alzheimer's Yet
SummaryBiogen brings back to life its Alzheimer’s drug Aducanumab.Share price substantially recovers but too soon to know if Aducanumab works.Even if it gets FDA approved, will . . .
Posted on 10/30/19
CAMP4 Therapeutics Appoints Steven Holtzman as Chair and Dr. Paula Ragan as Director
CAMP4 Therapeutics, a biotechnology company unraveling transcriptional machinery to accelerate drug discovery and development across therapeutic areas

